Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
International Journal of Colorectal Disease
Erschienen in: International Journal of Colorectal Disease 6/2018

27.03.2018 | Review

Chronic diarrhoea following surgery for colon cancer—frequency, causes and treatment options

verfasst von: Jonathan Yde, Helene M. Larsen, Søren Laurberg, Klaus Krogh, Hanne B. Moeller

Erschienen in: International Journal of Colorectal Disease | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The growing population of survivors after colon cancer warrants increased attention to the long-term outcome of surgical treatment. The change in bowel anatomy after resection disrupts normal gastrointestinal function and may cause symptoms. Thus, many patients surviving colon cancer have to cope with bowel dysfunction for the rest of their lives. We here aim to provide an overview of the literature on this topic.

Methods

We review long-term functional outcomes of surgical treatment for colon cancer, the underlying pathology, and treatment options.

Results

Common symptoms include constipation, urge for defecation and diarrhoea. Causes of diarrhoea after colon cancer surgery are sparsely studied, but they probably include bile acid malabsorption, small intestinal bacterial overgrowth and disruption of the ileal brake. Specific diagnosis should be made to allow individual treatment based on the underlying pathology. Studies on treatment of functional problems after surgery for colon cancer are extremely few, but some lessons can be drawn from the treatment of other patient groups having undergone colon surgery.

Conclusion

Diarrhoea is likely a common long-term complication after colon cancer surgery. Attention to this complication and a specific diagnosis will aid the targeted treatment of patients suffering from this complication.
Literatur
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386PubMedCrossRef
2.
3.
Brenner H, Hakulinen T (2001) Long-term cancer patient survival achieved by the end of the 20th century: most up-to-date estimates from the nationwide Finnish cancer registry. Br J Cancer 85(3):367–371PubMedPubMedCentralCrossRef
4.
Brenner H, Hakulinen T (2006) Up-to-date estimates of cancer patient survival even with common latency in cancer registration. Cancer Epidemiol Biomark Prev 15(9):1727–1732CrossRef
5.
Andreyev J, Ross P, Donnellan C, Lennan E, Leonard P, Waters C, Wedlake L, Bridgewater J, Glynne-Jones R, Allum W, Chau I, Wilson R, Ferry D (2014) Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol 15(10):e447–e460PubMedCrossRef
6.
Andreyev HJ (2016) GI consequences of cancer treatment: a clinical perspective. Radiat Res 185(4):341–348PubMedCrossRef
7.
Nord C, Mykletun A, Thorsen L, Bjoro T, Fossa SD (2005) Self-reported health and use of health care services in long-term cancer survivors. Int J Cancer 114(2):307–316PubMedCrossRef
8.
Theodoropoulos GE, Karantanos T, Stamopoulos P, Zografos G (2013) Prospective evaluation of health-related quality of life after laparoscopic colectomy for cancer. Tech Coloproctol 17(1):27–38PubMedCrossRef
9.
Sprangers MA, Taal BG, Aaronson NK, te Velde A (1995) Quality of life in colorectal cancer. Stoma vs nonstoma patients. Dis Colon Rectum 38(4):361–369PubMedCrossRef
10.
Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H (2006) Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: a population based study. Eur J Cancer 42(12):1848–1857PubMedCrossRef
11.
Emmertsen KJ, Laurberg S (2012) Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg 255(5):922–928PubMedCrossRef
12.
Juul T, Ahlberg M, Biondo S, Espin E, Jimenez LM, Matzel KE, Palmer GJ, Sauermann A, Trenti L, Zhang W, Laurberg S, Christensen P (2014) Low anterior resection syndrome and quality of life: an international multicenter study. Dis Colon Rectum 57(5):585–591PubMedCrossRef
13.
Manceau G, d'Annunzio E, Karoui M, Breton S, Rousseau G, Blanchet AS, Vaillant JC, Hannoun L (2013) Elective subtotal colectomy with ileosigmoid anastomosis for colon cancer preserves bowel function and quality of life. Color Dis 15(9):1078–1085
14.
Duclos J, Lefevre JH, Lefrancois M, Lupinacci R et al (2014) Immediate outcome, long-term function and quality of life after extended colectomy with ileorectal or ileosigmoid anastomosis. Color Dis 16(8):O288–O296CrossRef
15.
Papa MZ, Karni T, Koller M, Klein E, Scott D, Bersuk D, Sareli M, Ben Ari G (1997) Avoiding diarrhea after subtotal colectomy with primary anastomosis in the treatment of colon cancer. J Am Coll Surg 184(3):269–272PubMed
16.
You YN, Chua HK, Nelson H, Hassan I, Barnes SA, Harrington J (2008) Segmental vs. extended colectomy: measurable differences in morbidity, function, and quality of life. Dis Colon Rectum 51(7):1036–1043PubMedCrossRef
17.
Ho YH, Low D, Goh HS (1996) Bowel function survey after segmental colorectal resections. Dis Colon Rectum 39(3):307–310PubMedCrossRef
18.
Ohigashi S, Hoshino Y, Ohde S, Onodera H (2011) Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer. Surg Today 41(9):1200–1206PubMedCrossRef
19.
Magdeburg J, Glatz N, Post S, Kienle P, Rickert A (2016) Long-term functional outcome of colonic resections: how much does faecal impairment influence quality of life? Color Dis 18(11):O405–O413CrossRef
20.
21.
Haanstra JF, de Vos Tot Nederveen Cappel WH, Gopie JP, Vecht J et al (2012) Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy. Dis Colon Rectum 55(6):653–659PubMedCrossRef
22.
Theodoropoulos GE, Papanikolaou IG, Karantanos T, Zografos G (2013) Post-colectomy assessment of gastrointestinal function: a prospective study on colorectal cancer patients. Tech Coloproctol 17(5):525–536PubMedCrossRef
23.
Folaranmi S, Rakoczy G, Bruce J, Humphrey G, Bowen J, Morabito A, Kapur P, Morecroft J, Craigie R, Cserni T (2011) Ileocaecal valve: how important is it? Pediatr Surg Int 27(6):613–615PubMedCrossRef
24.
Cummings JH, James WP, Wiggins HS (1973) Role of the colon in ileal-resection diarrhoea. Lancet 1(7799):344–347PubMedCrossRef
25.
Mitchell JE, Breuer RI, Zuckerman L, Berlin J, Schilli R, Dunn JK (1980) The colon influences ileal resection diarrhea. Dig Dis Sci 25(1):33–41PubMedCrossRef
26.
Walters JR (2014) Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol 11(7):426–434PubMedCrossRef
27.
28.
Russell DW (2003) The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72:137–174PubMedCrossRef
29.
Holt JA, Luo G, Billin AN, Bisi J, McNeill Y, Kozarsky KF, Donahee M, Wang DY, Mansfield TA, Kliewer SA, Goodwin B, Jones SA (2003) Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17(13):1581–1591PubMedPubMedCentralCrossRef
30.
31.
Davis RA, Attie AD (2008) Deletion of the ileal basolateral bile acid transporter identifies the cellular sentinels that regulate the bile acid pool. Proc Natl Acad Sci U S A 105(13):4965–4966PubMedPubMedCentralCrossRef
32.
Aldini R, Roda A, Festi D, Sama C, Mazzella G, Bazzoli F, Morselli AM, Roda E, Barbara L (1982) Bile acid malabsorption and bile acid diarrhea in intestinal resection. Dig Dis Sci 27(6):495–502PubMedCrossRef
33.
Hofmann AF (1972) Bile acid malabsorption caused by ileal resection. Arch Intern Med 130(4):597–605PubMedCrossRef
34.
Kirwan WO, Smith AN, Mitchell WD, Falconer JD, Eastwood MA (1975) Bile acids and colonic motility in the rabbit and the human. Gut 16(11):894–902PubMedPubMedCentralCrossRef
35.
Flynn M, Darby C, Hyland J, Hammond P, Taylor I (1979) The effect of bile acids on colonic myoelectrical activity. Br J Surg 66(11):776–779PubMedCrossRef
36.
Alemi F, Poole DP, Chiu J, Schoonjans K, Cattaruzza F, Grider JR, Bunnett NW, Corvera CU (2013) The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology 144(1):145–154PubMedCrossRef
37.
Barcelo A, Claustre J, Toumi F, Burlet G, Chayvialle JA, Cuber JC, Plaisancie P (2001) Effect of bile salts on colonic mucus secretion in isolated vascularly perfused rat colon. Dig Dis Sci 46(6):1223–1231PubMedCrossRef
38.
Ao M, Sarathy J, Domingue J, Alrefai WA, Rao MC (2013) Chenodeoxycholic acid stimulates Cl(−) secretion via cAMP signaling and increases cystic fibrosis transmembrane conductance regulator phosphorylation in T84 cells. Am J Physiol Cell Physiol 305(4):C447–C456PubMedPubMedCentralCrossRef
39.
Keely SJ, Scharl MM, Bertelsen LS, Hagey LR, Barrett KE, Hofmann AF (2007) Bile acid-induced secretion in polarized monolayers of T84 colonic epithelial cells: structure-activity relationships. Am J Physiol Gastrointest Liver Physiol 292(1):G290–G297PubMedCrossRef
40.
Dharmsathaphorn K, Huott PA, Vongkovit P, Beuerlein G, Pandol SJ, Ammon HV (1989) Cl- secretion induced by bile salts. A study of the mechanism of action based on a cultured colonic epithelial cell line. J Clin Invest 84(3):945–953PubMedPubMedCentralCrossRef
41.
Devor DC, Sekar MC, Frizzell RA, Duffey ME (1993) Taurodeoxycholate activates potassium and chloride conductances via an IP3-mediated release of calcium from intracellular stores in a colonic cell line (T84). J Clin Invest 92(5):2173–2181PubMedPubMedCentralCrossRef
42.
Kunzelmann K, Mall M (2002) Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82(1):245–289PubMedCrossRef
43.
Loo DD, Hirayama BA, Meinild AK, Chandy G, Zeuthen T, Wright EM (1999) Passive water and ion transport by cotransporters. J Physiol 518(Pt 1):195–202PubMedPubMedCentralCrossRef
44.
Farack UM, Nell G, Lueg O, Rummel W (1982) Independence of the activation of mucus and potassium secretion on the inhibition of sodium and water absorption by deoxycholate in rat colon. Naunyn Schmiedeberg's Arch Pharmacol 321(4):336–340CrossRef
45.
Yde J K S, Wu Q, Borg JF, Lajczak N, O’Dwyer A, Dalsgaard P, Fenton RA, Moeller HB (2016) Characterization of AQPs in mouse, rat and human colon and their selective regulation by bile acids. Frontiers in nutrition, section Gastrointestinal Sciences
46.
Orekoya O, McLaughlin J, Leitao E, Johns W, Lal S, Paine P (2015) Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy. Clin Med (Lond) 15(4):371
47.
Borghede MK, Schlutter JM, Agnholt JS, Christensen LA, Gormsen LC, Dahlerup JF (2011) Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea. Eur J Intern Med 22(6):e137–e140PubMedCrossRef
48.
Nyhlin H, Merrick MV, Eastwood MA (1994) Bile acid malabsorption in Crohn’s disease and indications for its assessment using SeHCAT. Gut 35(1):90–93PubMedPubMedCentralCrossRef
49.
Sciarretta G, Vicini G, Fagioli G, Verri A, Ginevra A, Malaguti P (1986) Use of 23-selena-25-homocholyltaurine to detect bile acid malabsorption in patients with illeal dysfunction or diarrhea. Gastroenterology 91(1):1–9PubMedCrossRef
50.
Jewkes AJ, Windsor CW, Ward RS, Timmins AE (1989) Relationship between bile acid malabsorption using the 75Se homocholic acid taurine scanning method and diarrhoea following right hemicolectomy. Br J Surg 76(7):707–708PubMedCrossRef
51.
Phillips F, Muls AC, Lalji A, Andreyev HJ (2015) Are bile acid malabsorption and bile acid diarrhoea important causes of loose stool complicating cancer therapy? Color Dis 17(8):730–734CrossRef
52.
Grace E, Shaw C, Whelan K, Andreyev HJ (2013) Review article: small intestinal bacterial overgrowth—prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther 38(7):674–688PubMedCrossRef
53.
54.
Quigley EM (2013) Gut bacteria in health and disease. Gastroenterol Hepatol (N Y) 9(9):560–569
55.
Mathias JR, Clench MH (1985) Review: pathophysiology of diarrhea caused by bacterial overgrowth of the small intestine. Am J Med Sci 289(6):243–248PubMedCrossRef
56.
Elphick DA, Chew TS, Higham SE, Bird N, Ahmad A, Sanders DS (2005) Small bowel bacterial overgrowth in symptomatic older people: can it be diagnosed earlier? Gerontology 51(6):396–401PubMedCrossRef
57.
Theodoropoulos GE, Memos NA, Peitsidou K, Karantanos T, Spyropoulos BG, Zografos G (2016) Synbiotics and gastrointestinal function-related quality of life after elective colorectal cancer resection. Ann Gastroenterol 29(1):56–62PubMedPubMedCentral
58.
Van Citters GW, Lin HC (2006) Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 8(5):367–373PubMedCrossRef
59.
Maljaars PW, Peters HP, Mela DJ, Masclee AA (2008) Ileal brake: a sensible food target for appetite control. A review. Physiol Behav 95(3):271–281PubMedCrossRef
60.
Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ (1993) Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38(4):665–673PubMedCrossRef
61.
62.
Eissele R, Goke R, Willemer S, Harthus HP, Vermeer H, Arnold R, Goke B (1992) Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Investig 22(4):283–291CrossRef
63.
Aranha GV, Walsh RM, Jacobs HK, Freeark RJ, Harford FJ, Keshavarzian A, Zarling EJ (1996) Factors influencing bowel function following total abdominal colectomy. Dis Colon Rectum 39(12):1418–1422PubMedCrossRef
64.
Gracie DJ, Kane JS, Mumtaz S, Scarsbrook AF, Chowdhury FU, Ford AC (2012) Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil 24(11):983–e538PubMedCrossRef
65.
Smith MJ, Cherian P, Raju GS, Dawson BF, Mahon S, Bardhan KD (2000) Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond 34(5):448–451PubMed
66.
Lenicek M, Duricova D, Komarek V, Gabrysova B, Lukas M, Smerhovsky Z, Vitek L (2011) Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers. Inflamm Bowel Dis 17(6):1322–1327PubMedCrossRef
67.
Brydon WG, Nyhlin H, Eastwood MA, Merrick MV (1996) Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol 8(2):117–123PubMedCrossRef
68.
Pattni SS, Brydon WG, Dew T, Walters JR (2012) Fibroblast growth factor 19 and 7alpha-hydroxy-4-cholesten-3-one in the diagnosis of patients with possible bile acid diarrhea. Clin Transl Gastroenterol 3:e18PubMedPubMedCentralCrossRef
69.
Vijayvargiya P, Camilleri M, Shin A, Saenger A (2013) Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol 11(10):1232–1239PubMedPubMedCentralCrossRef
70.
Lundasen T, Galman C, Angelin B, Rudling M (2006) Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 260(6):530–536PubMedCrossRef
71.
Husebye E (2005) The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 51(Suppl 1):1–22PubMedCrossRef
72.
73.
Gronlund D, Poulsen JL, Sandberg TH, Olesen AE, et al. (2017) Established and emerging methods for assessment of small and large intestinal motility. Neurogastroenterol Motil
74.
Bonapace ES, Maurer AH, Davidoff S, Krevsky B, Fisher RS, Parkman HP (2000) Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J Gastroenterol 95(10):2838–2847PubMedCrossRef
75.
Wilcox C, Turner J, Green J (2014) Systematic review: the management of chronic diarrhoea due to bile acid malabsorption. Aliment Pharmacol Ther 39(9):923–939PubMedCrossRef
76.
Jacobsen O, Hojgaard L, Hylander Moller E, Wielandt TO, Thale M, Jarnum S, Krag E (1985) Effect of enterocoated cholestyramine on bowel habit after ileal resection: a double blind crossover study. Br Med J (Clin Res Ed) 290(6478):1315–1318CrossRef
77.
Luman W, Williams AJ, Merrick MV, Eastwood MA (1995) Idiopathic bile acid malabsorption: long-term outcome. Eur J Gastroenterol Hepatol 7(7):641–645PubMed
78.
Fernandez-Banares F, Rosinach M, Piqueras M, Ruiz-Cerulla A et al (2015) Randomised clinical trial: colestyramine vs. hydroxypropyl cellulose in patients with functional chronic watery diarrhoea. Aliment Pharmacol Ther 41(11):1132–1140PubMedCrossRef
79.
Beigel F, Teich N, Howaldt S, Lammert F, Maul J, Breiteneicher S, Rust C, Göke B, Brand S, Ochsenkühn T (2014) Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn’s disease: a randomized, double-blind, placebo-controlled study. J Crohns Colitis 8(11):1471–1479PubMedCrossRef
80.
Bajor A, Tornblom H, Rudling M, Ung KA, Simren M (2015) Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. Gut 64(1):84–92PubMedCrossRef
81.
Gupta A, Muls AC, Lalji A, Thomas K, Watson L, Shaw C, Andreyev HJ (2015) Outcomes from treating bile acid malabsorption using a multidisciplinary approach. Support Care Cancer 23(10):2881–2890PubMedCrossRef
82.
Watson L, Lalji A, Bodla S, Muls A, Andreyev HJ, Shaw C (2015) Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome? Clin Med (Lond) 15(6):536–540CrossRef
83.
Walters JR, Johnston IM, Nolan JD, Vassie C, Pruzanski ME, Shapiro DA (2015) The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid. Aliment Pharmacol Ther 41(1):54–64PubMedCrossRef
84.
Shah SC, Day LW, Somsouk M, Sewell JL (2013) Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther 38(8):925–934PubMedCrossRef
85.
Gatta L, Scarpignato C (2017) Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther 45(5):604–616PubMedPubMedCentralCrossRef
86.
Nelson LM, Carmichael HA, Russell RI, Atherton ST (1977) Use of an elemental diet (Vivonex) in the management of bile acid-induced diarrhoea. Gut 18(10):792–794PubMedPubMedCentralCrossRef
87.
Mainguet P, Fiasse R (1977) Double-blind placebo-controlled study of loperamide (Imodium) in chronic diarrhoea caused by ileocolic disease or resection. Gut 18(7):575–579PubMedPubMedCentralCrossRef
88.
Mainguet P, Fiasse R, Turine JB (1977) Long-term survey of the treatment of diarrhoea with loperamide. Digestion 16(1–2):69–76PubMedCrossRef
89.
Bergman L, Djarv L (1981) A comparative study of loperamide and diphenoxylate in the treatment of chronic diarrhoea caused by intestinal resection. Ann Clin Res 13(6):402–405PubMed
90.
91.
Mortensen PB, Andersen JR, Arffmann S, Krag E (1987) Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran. Scand J Gastroenterol 22(2):185–192PubMedCrossRef
92.
Qvitzau S, Matzen P, Madsen P (1988) Treatment of chronic diarrhoea: loperamide versus ispaghula husk and calcium. Scand J Gastroenterol 23(10):1237–1240PubMedCrossRef
93.
Markland AD, Burgio KL, Whitehead WE, Richter HE, Wilcox CM, Redden DT, Beasley TM, Goode PS (2015) Loperamide versus psyllium fiber for treatment of fecal incontinence: the fecal incontinence prescription (Rx) management (FIRM) randomized clinical trial. Dis Colon Rectum 58(10):983–993PubMedCrossRef
94.
Eherer AJ, Santa Ana CA, Porter J, Fordtran JS (1993) Effect of psyllium, calcium polycarbophil, and wheat bran on secretory diarrhea induced by phenolphthalein. Gastroenterology 104(4):1007–1012PubMedCrossRef
95.
Roediger WE, Rigol G, Rae D (1984) Sodium absorption with bacterial fatty acids and bile salts in the proximal and distal colon as a guide to colonic resection. Dis Colon Rectum 27(1):1–5PubMedCrossRef
96.
Meier R, Beglinger C, Schneider H, Rowedder A, Gyr K (1993) Effect of a liquid diet with and without soluble fiber supplementation on intestinal transit and cholecystokinin release in volunteers. JPEN J Parenter Enteral Nutr 17(3):231–235PubMedCrossRef
97.
Washington N, Harris M, Mussellwhite A, Spiller RC (1998) Moderation of lactulose-induced diarrhea by psyllium: effects on motility and fermentation. Am J Clin Nutr 67(2):317–321PubMedCrossRef
Metadaten
Titel
Chronic diarrhoea following surgery for colon cancer—frequency, causes and treatment options
verfasst von
Jonathan Yde
Helene M. Larsen
Søren Laurberg
Klaus Krogh
Hanne B. Moeller
Publikationsdatum
27.03.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 6/2018
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-018-2993-y

Weitere Artikel der Ausgabe 6/2018

International Journal of Colorectal Disease 6/2018 Zur Ausgabe

Original Article

The prognostic implications of primary tumor location on recurrence in early-stage colorectal cancer with no associated risk factors

Letter to the Editor

Hemorrhoidal disease: is it time for a new classification?

Original Article

Retromesenteric course of the middle colic artery—challenges and pitfalls in D3 right colectomy for cancer

Short Communication

Perianal minimally invasive surgery (PAMIS) for rectal stump resection after previous colectomy

Original Article

Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study)

Original Article

Pathologic factors are more important than tumor location in long-term survival in colon cancer

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.
Bildnachweise